Toggle navigation
Home
Search
Services
Blog
Contact
About
Apoptosis Inhibitors - Therapy for Neurotoxicity
Pulliam, Lynn
Neurex Corporation, Menlo Park, CA, United States
Search 44 grants from Lynn Pulliam
Search grants from Neurex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targeting Anhedonia in Cocaine Use Disorder
Impact of aging on salivary stem cells and organ regeneration
Indiana Medical Scientist/Engineer Training Program
Wisc - to Prevent & Control and Promote School Health
Health Promotion/Disability Prevention - Second Fifty
Recently added grants:
Mechanisms and significance of intestinal cell proliferation in Vibrio parahaemolyticus infection
Functional immune tolerance to non-inherited maternal antigen
Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection
Epigenetic Reprogramming of Monocyte Functions during Acute Uncomplicated Malaria in Kenyan Children
Combatting natural resistance and persistence in non-TB mycobacterial disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41MH056311-01
Application #
2256468
Study Section
Small Business Research Review Committee (MHSB)
Project Start
1996-08-01
Project End
1997-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Neurex Corporation
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Publications
Pulliam, L; Zhou, M; Stubblebine, M et al.
(1998)
Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor.
J Neurosci Res 54:530-8
Comments
Be the first to comment on Lynn Pulliam's grant